The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Efficacy of an Acellular Pertussis Vaccine among Adolescents and Adults
Abstract
BACKGROUND: Pertussis immunization of adults may be necessary to improve the control of a rising burden of disease and infection. This trial of an acellular pertussis vaccine among adolescents and adults evaluated the incidence of pertussis, vaccine safety, immunogenicity, and protective efficacy. METHODS: Bordetella pertussis infections and illnesses were prospectively assessed in 2781 healthy subjects between the ages of 15 and 65 years who were enrolled in a national multicenter, randomized, double-blind trial of an acellular pertussis vaccine. Subjects received either a dose of a tricomponent acellular pertussis vaccine or a hepatitis A vaccine (control) and were monitored for 2.5 years for illnesses with cough that lasted for more than 5 days. Each illness was evaluated with use of a nasopharyngeal aspirate for culture and polymerase-chain-reaction assay, and serum samples from patients in both acute and convalescent stages of illness were analyzed for changes in antibodies to nine B. pertussis antigens. RESULTS: Of the 2781 subjects, 1391 received the acellular pertussis vaccine and 1390 received the control vaccine. The groups had similar ages and demographic characteristics, and the median duration of follow-up was 22 months. The acellular pertussis vaccine was safe and immunogenic. There were 2672 prolonged illnesses with cough, but the incidence of this nonspecific outcome did not vary between the groups, even when stratified according to age, season, and duration of cough. On the basis of the primary pertussis case definition, vaccine protection was 92 percent (95 percent confidence interval, 32 to 99 percent). Among unimmunized controls with illness, 0.7 percent to 5.7 percent had B. pertussis infection, and the percentage increased with the duration of cough. On the basis of other case definitions, the incidence of pertussis in the controls ranged from 370 to 450 cases per 100,000 person-years. CONCLUSIONS: The acellular pertussis vaccine was protective among adolescents and adults, and its routine use might reduce the overall disease burden and transmission to children.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Infant Pertussis: Who Was the Source?
Bisgard, K. M., Pascual, F. B., Ehresmann, K. R., Miller, C. A., Cianfrini, C., Jennings, C. E., Rebmann, C. A., Gabel, J., Schauer, S. L., & Lett, S. M. (2004) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000145263.37198.2b · Cited by 403
Trends in Pertussis Among Infants in the United States, 1980-1999
Tanaka, M. (2003) · JAMA · doi:10.1001/jama.290.22.2968 · Cited by 335
Severe and unrecognised: pertussis in UK infants
Crowcroft, N. S. (2003) · Archives of Disease in Childhood · doi:10.1136/adc.88.9.802 · Cited by 283
A Search for Bordetella pertussis Infection in University Students
Mink, C. M., Cherry, J. D., Christenson, P., Lewis, K., Pineda, E., Shlian, D., Dawson, J. A., & Blumberg, D. A. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.2.464 · Cited by 268
Self-citationCherry, J. D. (2005) · Pediatrics · doi:10.1542/peds.2004-2648 · Cited by 237
Self-citationPopulation‐Based Incidence of Pertussis among Adolescents and Adults, Minnesota, 1995–1996
Strebel, P., Nordin, J., Edwards, K., Hunt, J., Besser, J., Burns, S., Amundson, G., Baughman, A., & Wattigney, W. (2001) · The Journal of Infectious Diseases · doi:10.1086/319853 · Cited by 223
Self-citationCherry, J. D. (1984) · Current Problems in Pediatrics · doi:10.1016/0045-9380(84)90016-1 · Cited by 193
Self-citationEpidemiological, Clinical, and Laboratory Aspects of Pertussis in Adults
Cherry, J. D. (1999) · Clinical Infectious Diseases · doi:10.1086/515058 · Cited by 192
Self-citationHousehold Contact Study of Bordetella pertussis Infections
Deen, J. L., Mink, C. M., Cherry, J. D., Christenson, P. D., Pineda, E. F., Lewis, K., Blumberg, D. A., & Ross, L. A. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.5.1211 · Cited by 189
Self-citationLe, T., Cherry, J. D., Chang, S., Knoll, M. D., Lee, M. L., Barenkamp, S., Bernstein, D., Edelman, R., Edwards, K. M., Greenberg, D., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/422035 · Cited by 160
Self-citationBauer, H. M. (1991) · JAMA · doi:10.1001/jama.265.4.472 · Cited by 155
Adolescent and adult pertussis vaccination: computer simulations of five new strategies
Rie, A. V., & Hethcote, H. W. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.01.067 · Cited by 135
Specific identification of Bordetella pertussis by the polymerase chain reaction
Houard, S. A., Hackel, C., HERZOG, A., & Bollen, A. (1989) · Research in Microbiology · doi:10.1016/0923-2508(89)90069-7 · Cited by 126
Cited by
Mandell, L. A., Wunderink, R. G., Anzueto, A., Bartlett, J. G., Campbell, G. D., Dean, N. C., Dowell, S. F., File, T. M., Musher, D. M., Niederman, M. S., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/511159 · Cited by 6,202
Statistical physics of vaccination
Wang, Z., Bauch, C. T., Bhattacharyya, S., d'Onofrio, A., Manfredi, P., Perc, M., Perra, N., Salathé, M., & Zhao, D. (2016) · Physics Reports · doi:10.1016/j.physrep.2016.10.006 · Cited by 872
Pertussis: Microbiology, Disease, Treatment, and Prevention
Kilgore, P. E., Salim, A. M., Zervos, M. J., & Schmitt, H.-J. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00083-15 · Cited by 434
Pertussis: review of epidemiology, diagnosis, management and prevention
Wood, N., & McIntyre, P. (2008) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2008.05.010 · Cited by 264
Recent developments in pertussis
Crowcroft, N. S., & Pebody, R. G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68848-x · Cited by 256
Metadata
- Authors
- Ward, J. I., Cherry, J. D., Chang, S.-J., Partridge, S., Lee, H., Treanor, J., Greenberg, D. P., Keitel, W., Barenkamp, S., Bernstein, D. I., Edelman, R., & Edwards, K.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-10-13
- Volume
- 353
- Issue
- 15
- Pages
- 1555-1563
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2036897121
- Cited by
- 380
- References
- 13
- FWCI
- 30.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.